ExLibris header image
SFX Logo
Title: Beyond Warburg effect – dual metabolic nature of cancer cells
Source:

Scientific Reports [2045-2322] yr:2014


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Full text available via PubMed Central Open Access
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Wu, W. "Metabolic changes in cancer: beyond the Warburg effect." Acta Biochimica et Biophysica Sinica 45.1 (2013): 18-26. Link to Full Text for this item Link to SFX for this item
2. Razungles, J. "L’effet Warburg." Médecine sciences 29.11 (2013): 1026-1033. Link to SFX for this item
3. Lee, J. "Cancer cell metabolism: implications for therapeutic targets." Experimental and Molecular Medicine 45.10 (2013). Link to Full Text for this item Link to SFX for this item
4. Belkaid, A. "Silencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: potential new anticancer target for curcumin." FEBS letters 580.15 (2006): 3746-52. Link to Full Text for this item Link to SFX for this item
5. Mantovani, G. "Managing cancer-related anorexia/cachexia." Drugs 61.4 (2001): 499-514. Link to SFX for this item
6. Pollard, Patrick J. "Oncometabolites: linking altered metabolism with cancer." The Journal of clinical investigation 123.9 (2013): 3652-3658. Link to Full Text for this item Link to SFX for this item
7. Wong, N. "PKM2, a central point of regulation in cancer metabolism." International Journal of Cell Biology 2013 (2013): 1-242513. Link to Full Text for this item Link to SFX for this item
8. Koppenol, W. "Otto Warburg's contributions to current concepts of cancer metabolism." Nature Reviews. Cancer 11.5 (2011): 325-337. Link to SFX for this item
9. Leuzzi, R. "Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b." Blood 101.6 (2003): 2381-7. Link to SFX for this item
10. Ferreira, Leonardo M R M. "Cancer metabolism: The Warburg effect today." Experimental and Molecular Pathology 89.3 (2010): 372-80. Link to SFX for this item
11. Pathania, D. "Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism." Advanced Drug Delivery Reviews 61.14 (2009): 1250-1275. Link to SFX for this item
12. Kohira, T. "Artificial receptors designed for intracellular delivery of anionic phosphate derivatives." Chembiochem 9.5 (2008): 698-701. Link to Full Text for this item Link to SFX for this item
13. Argiles, F J M. "The metabolic basis of cancer cachexia." Medicinal research reviews 17.5 (1997): 477-98. Link to Full Text for this item Link to SFX for this item
14. González Villarroel, P. "Megestrol acetate-induced adrenal insufficiency." Clinical and Translational Oncology 10.4 (2008): 235-7. Link to SFX for this item
15. Flachner, Beáta, B. "Substrate-Assisted Movement of the Catalytic Lys 215 during Domain Closure: Site-Directed Mutagenesis Studies of Human 3-Phosphoglycerate Kinase." Biochemistry 44.51 (2005): 16853-16865. Link to Full Text for this item Link to SFX for this item
16. S, A. "Cancer-induced fatigue and skeletal muscle wasting : the role of exercise." Biological research for nursing 2.3 (2001): 186-197. Link to Full Text for this item Link to SFX for this item
17. Pascual López, A. "Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome." Journal of pain and symptom management 27.4: 360-369. Link to SFX for this item
18. Orr, R. "The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety." Drugs 64.7 (2004): 725-50. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced